Literature DB >> 14522866

Preventing accidental transmission of human transmissible spongifom encephalopathies.

David M Taylor1.   

Abstract

The mechanism by which humans became infected with the BSE agent is discussed, and the matter of potential person-to person transmission of TSEs through contagion or medical procedures is considered. There is some discussion regarding the current evidence relating to whether or not the blood of humans infected with TSEs is infectious. Considerable emphasis is placed on the fact that TSE agents are known to be relatively resistant to decontamination by procedures that are effective with conventional micro-organisms, including (under worst-case conditions) the autoclaving procedures used to sterilise surgical instruments. Methods for providing additional re-assurance with regard to the safety of instruments are described. Safety in the pathology laboratory is discussed extensively because TSE agents are not inactivated by the usual processes used to fix tissues, and such laboratories will receive fixed tissues that are still highly infectious as far as TSE agents are concerned.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522866     DOI: 10.1093/bmb/66.1.293

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  2 in total

1.  Mapping Biological Risks Related to Necropsy Activities: Old Concerns and Novel Issues for the Safety of Health Professionals.

Authors:  Paola Tomao; Raffaele La Russa; Alessandra Oliva; Massimiliano De Angelis; Antonella Mansi; Emilia Paba; Anna Maria Marcelloni; Alessandra Chiominto; Martina Padovano; Aniello Maiese; Matteo Scopetti; Paola Frati; Vittorio Fineschi
Journal:  Int J Environ Res Public Health       Date:  2021-11-13       Impact factor: 3.390

2.  Ocular Tonometry and Sporadic Creutzfeldt - Jakob Disease (sCJD): A Confirmatory Case-Control Study.

Authors:  Zoreh Davanipour; Eugene Sobel; Argyrios Ziogas; Carey Smoak; Thomas Bohr; Keith Doram; Boleslaw Liwnicz
Journal:  Br J Med Med Res       Date:  2014-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.